CAPR News

Pomerantz LLP Issues Reminder to Investors in Capricor Therapeutics, Inc. of Class Action Filing – CAPR

CAPR INVESTOR DEADLINE: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit

ROSEN, TRUSTED TRIAL ATTORNEYS, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CAPR

Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Capricor Therapeutics, Inc. and Encourages Investors to Contact the Firm

Kaplan Fox Notifies Investors of Pentair plc (PNR) of a Securities Fraud Class Action Deadline on October 2, 2026 Ready to Announce with Confidence?

Kaplan Fox Reminds Investors of Capricor Therapeutics, Inc. (CAPR) to a Securities Class Action Deadline - Contact the Firm Before September 28, 2026 Ready to Announce with Confidence?

CAPR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Capricor Therapeutics, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!

Bronstein, Gewirtz & Grossman LLC Urges Capricor Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

CAPR Shareholder Alert: Capricor Therapeutics, Inc. Securities Class Action Lawsuit - Investors With Losses May Contact Levi & Korsinsky

Faruqi & Faruqi, LLP Urges Capricor Therapeutics, Inc. (CAPR) Investors to Seek Counsel Before the September 28, 2026 Lead Plaintiff Deadline in the Securities Class Action Ready to Announce with Confidence?